NSC 366140 無結構圖
中文名稱 | NSC 366140 無結構圖 |
---|---|
中文同義詞 | NSC 366140 無結構圖;化合物 T28475;化合物PYRAZOLOACRIDINE;化合物PYRAZOLOACRIDINE,10 MM DMSO 溶液 |
英文名稱 | NSC 366140 |
英文同義詞 | Pyrazolo(3,4,5-kl)acridine-2(6H)-propanamine, N,N-dimethyl-9-methoxy-5-nitro-;(3-(9-METHOXY-5-NITRO-6H-PYRAZOLO(3,4,5-KL)ACRIDIN-2-YL)-PROPYL)-DIMETHYL-AMINE;NSC 366140;2,6-Dihydro-2-(3-dimethylaminopropyl)-9-methoxy-5-nitropyrazolo[3,4,5-kl]acridine;9-Methoxy-N,N-dimethyl-5-nitropyrazolo[3,4,5-kl]acridine-2(6H)-propane-1-amine;Pyrazoloacridine;1,2,6,10b-Tetrahydro-5-nitro-9-methoxy-2-[3-(dimethylamino)propyl]pyrazolo[3,4,5-kl]acridine;Brn 4211902 |
CAS號 | 99009-20-8 |
分子式 | C19H21N5O3 |
分子量 | 367.4 |
EINECS號 | |
相關類別 | |
Mol文件 | 99009-20-8.mol |
結構式 | ![]() |
NSC 366140 無結構圖 性質
沸點 | 584.3±50.0 °C(Predicted) |
---|---|
密度 | 1.38±0.1 g/cm3(Predicted) |
儲存條件 | Store at -20°C |
酸度系數(shù)(pKa) | 9.35±0.28(Predicted) |
形態(tài) | 固體 |
顏色 | 淺棕色至橙色 |
Pyrazoloacridine (NSC 366140, PD 115934) exhibits IC
50
values of 10.7 μM and 4.5 μM for oxic and hypoxic HCT-8 cells.
Pyrazoloacridine (NSC 366140, 2-4 μM) abolishes the catalytic activity of both topo I and topo II in vitro.
Pyrazoloacridine (NSC 366140) displays activity against cisplatin- and paclitaxel-resistant ovarian cancer.
Pyrazoloacridine (NSC 366140) has been shown to cause delayed DNA fragmentation in MCF-7 breast cancer cells.
Pyrazoloacridine (NSC 366140) induces
apoptosis
in P53-deficient Hep 3B human hepatoma cells.
Cell Cytotoxicity Assay
Cell Line: | K562 Myeloid Leukemia Cells. |
Concentration: | 0-500 μM. |
Incubation Time: | 1 h or 24 h. |
Result: | When K562 cells were incubated with PA for 1 h and then plated in soft agar, an IC 50 of -50 μM was observed. In contrast, when cells were incubated for 24 h with PA, the IC 50 was 1.25 μM. |
安全信息
更新日期 | 產品編號 | 產品名稱 | CAS號 | 包裝 | 價格 |
---|---|---|---|---|---|
2025/02/08 | HY-108969 | NSC 366140 無結構圖 Pyrazoloacridine | 99009-20-8 | 1 mg | 466元 |
2025/02/08 | HY-108969 | NSC 366140 無結構圖 Pyrazoloacridine | 99009-20-8 | 10 mM * 1 mLin DMSO | 727元 |